The Biology and Diagnosis of IgG4-RPF

Understanding the biology of IgG4-related retroperitoneal fibrosis (IgG4-RPF) helps explain why your body is creating scar tissue where it shouldn’t. While the name focuses on IgG4 (an antibody), the disease is actually driven by a complex “conversation” between different parts of your immune system.

The Biological “False Alarm”

In a healthy body, your immune system uses inflammation to heal wounds. In IgG4-RD, this process gets stuck in the “on” position.

1. The Drivers (T-cells): Specialized immune cells called cytotoxic CD4+ T cells and follicular helper T cells enter the retroperitoneal tissue ^[1][2]. These cells send out chemical signals (cytokines) that act like a false alarm, telling the body there is a major injury that needs fixing ^[3].
2. The Builders (Fibroblasts): In response to these signals, “builder” cells called fibroblasts become hyperactive ^[3]. They begin churning out dense, ropey collagen—essentially creating a massive internal scar ^[1].
3. The Markers (B-cells & Plasma Cells): Another group of cells, B-cells, transform into plasma cells that produce IgG4 antibodies ^[4][5]. While we don’t think the IgG4 antibodies themselves cause the damage, they serve as a critical “fingerprint” that doctors use to identify the disease ^[5][6].

Differentiating the “Mimics”

Because many conditions can cause a mass to grow in the back of the abdomen, a biopsy (taking a small tissue sample) is the gold standard for diagnosis ^[7][8]. Doctors must rule out two main “mimics”:

• Idiopathic Retroperitoneal Fibrosis (Ormond’s Disease): This looks almost identical to IgG4-RPF on a CT scan. However, when viewed under a microscope, idiopathic RPF lacks the high concentration of IgG4-positive plasma cells and the specific “woven” (storiform) pattern of scar tissue found in IgG4-RPF ^[5][6].
• Malignancies (Cancer): Certain cancers, such as lymphoma or metastatic tumors, can also cause retroperitoneal masses ^[7][9]. A biopsy allows pathologists to look for malignant (cancerous) cells versus the inflammatory cells typical of IgG4-RPF ^[8].

Because IgG4-RD is a systemic disease (meaning it can affect the whole body), your doctor will often order imaging of your chest, pancreas, or salivary glands to look for inflammation in those organs ^[10][11]. Finding the disease in multiple organs strongly supports the diagnosis of IgG4-RD and helps rule out an isolated cancer ^[12].

The 2023 Revised Diagnostic Criteria

In 2023, international experts updated the diagnostic criteria specifically for IgG4-related cardiovascular and retroperitoneal disease (IgG4-PA/RPF) to make diagnosis more accurate ^[13].

The revised criteria are designed to be more “sensitive,” meaning they help doctors catch the disease earlier and in more patients than previous versions ^[13]. Key updates include:

• Extra-organ Clues: If you have signs of IgG4-related disease in other organs (like the pancreas or salivary glands), it now counts more heavily toward a definitive diagnosis of the retroperitoneal mass ^[13].
• Radiological Markers: New specific imaging findings, such as inflammation around the heart (pericarditis), have been added as supporting evidence ^[13].
• Microscopic Details: The criteria now include very specific microscopic findings, such as the presence of eosinophils (a type of white blood cell) or lymphoid follicles in the tissue ^[13].

By using these updated rules, your medical team can more confidently distinguish IgG4-RPF from other conditions and start the correct treatment faster.